Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04300569 · ClinicalTrials.gov registry record
A Study to Determine the Signs and Symptoms That Impact Daily Life of Participants With Irregular Sleep-Wake Rhythm Disorder
A clinical trial, sponsored by Eisai.
- Completed
- Registry status
- 37
- Enrollment target
NCT04300569: Completed study, sponsored by Eisai.
NCT04300569 is a clinical trial that has completed, run by Eisai. The registered enrollment target is 37 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04300569 has completed, sponsored by Eisai.
- COMPLETED
- Registry status
- 37 participants
- Enrollment target
Study Summary
The primary purpose of this study is to determine the signs and symptoms of irregular sleep-wake rhythm disorder (ISWRD) that are important to patients and caregivers of patients with Alzheimer's disease dementia (AD-D), AD-D with cerebrovascular disease (CVD), and/or vascular dementia (VaD) and ISWRD, and to draft an instrument or instruments to assess them.
Primary Outcome
Development of scale for the assessment of the signs and symptoms of ISWRD based on interview data of participants using ATLAS ti Coding software will be reported. This study will determine the sleep-wake symptoms and signs that are the most relevant and important from the patient and caregiver perspectives.
Interventions
- OTHER Non-interventional
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 37 participants |
| Start Date | 2020-07-09 |
| Est. Completion | 2020-09-07 |
What the finished NCT04300569 record still lists
NCT04300569 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 37 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Non-interventional is the first listed.
NCT04300569 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04300569 about?
NCT04300569 is a clinical study titled "A Study to Determine the Signs and Symptoms That Impact Daily Life of Participants With Irregular Sleep-Wake Rhythm Disorder". The primary purpose of this study is to determine the signs and symptoms of irregular sleep-wake rhythm disorder (ISWRD) that are important to patients and caregivers of patients with Alzheimer's disease dementia (AD-D), AD-D with cerebrovascular disease (CVD), and/or vascular dementia (VaD) and ISW...
What is the current status of trial NCT04300569?
This trial is currently completed. The enrollment target is 37 participants. The study started on 2020-07-09. Estimated completion is 2020-09-07.
What interventions are being tested in trial NCT04300569?
The interventions under investigation include: Non-interventional (OTHER).
Who is sponsoring clinical trial NCT04300569?
This trial is sponsored by Eisai, which has 287 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02800486 · 37 participants · Phase 2
Super Selective Intra-arterial Repeated Infusion of Cetuximab (Erbitux) With Reirradiation for Treatment of Relapsed/Refractory GBM, AA, and AOA
- NCT03173937 · 37 participants · Phase 1
Unrelated Umbilical Cord Blood Transplantation for Severe Aplastic Anemia and Hypo-plastic MDS Using CordIn(TM), Umbilical Cord Blood-Derived Ex Vivo Expanded Stem and Progenitor Cells to Expedite Engraftment and Improve Transplant Outcome
- NCT03295227 · 37 participants · Phase 1
Pembrolizumab in Treating Participants With Unresectable Thymoma or Thymic Cancer
- NCT03401047 · 37 participants · Early Phase 1
Study to Assess Potential Impairments in Estradiol Augmentation of Gonadotropin Secretion in Polycystic Ovary Syndrome
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI